<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:mp ids='MP_0002899'>Fatigue</z:mp> and/or <z:e sem="disease" ids="C0016053" disease_type="Disease or Syndrome" abbrv="">Fibromyalgia</z:e> have long been diseases without definition </plain></SENT>
<SENT sid="1" pm="."><plain>An explanatory model of coagulation activation has been demonstrated through use of the ISAC panel of five tests, including, Fibrinogen, Prothrombin Fragment 1+2, Thrombin/ AntiThrombin Complexes, Soluble Fibrin Monomer, and Platelet Activation by flow cytometry </plain></SENT>
<SENT sid="2" pm="."><plain>These tests show low level coagulation activation from immunoglobulins (Igs) as demonstrated by Anti-B2GPI antibodies, which allows classification of these diseases as a type of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
<SENT sid="3" pm="."><plain>The ISAC panel allows testing for diagnosis as well as monitoring for anticoagulation protocols in these patients </plain></SENT>
</text></document>